In-network
psychiatry, nationwide.
Fast access, no cost.

Talkiatry expands in-network psychiatry access, seeing patients in days, with zero cost or admin burden.

30%

of top U.S. health
systems partner with us

Nearly a third of the Top 20 Health Systems in America trust Talkiatry to give their ambulatory and outpatient populations access to quality behavioral health care.

The hidden costs of untreated behavioral health

Downstream costs

Delays in access lead to more complex and costly care.

ED overuse

Lower-acuity patients occupy ED capacity.

Admin burden

Limited psychiatry access increases staff workload.

Refer down the hall. Nationwide.

Referring to psychiatry once meant walking a patient down the hall. Now, shortages and access gaps make that harder.

Talkiatry restores that same confidence at scale: Nationwide, in-network, with appointments in days. Virtual care delivers the quality and continuity of an in-house team, at no cost to your system.

Refer a patient

What your system gets when partnering with Talkiatry

Better access. Better outcomes. Less friction.

No costs, no contracts

Partnership is free to health systems with no commitments.

Fast access

Your patients are seen in days, not months.

Seamless referrals

Clear referral process with real-time patient updates.

Closed loop referrals

We keep your clinicians in the loop with progress notes.

Proven outcomes

Remission and response rates exceed national benchmarks.

Backed by data

Outcomes that lower costs and ease strain

In peer-reviewed studies of Talkiatry patients with anxiety and depression after 5 visits:

78%

Have a reduction in symptoms*

65%

Have no clinically significant symptoms*

28%

Report clinical
remission*

In a cohort analysis by a national insurer Talkiatry patients had:

68%

Fewer hospitalizations

32%

Fewer ER visits

$700

Savings per member per mo.

*65% of patients no longer reported clinically significant symptoms; Person C, O'Connor N, Koehler L, Venkatachalam K, Gaveras G; Evaluating Clinical Outcomes in Patients Being Treated Exclusively via Telepsychiatry: Retrospective Data Analysis; JMIR Form Res 2023;7:e53293; URL:https://formative.jmir.org/2023/1/e53293 DOI: 10.2196/53293. Outcomes data based on retrospective study of de-identified data from 1,826 Talkiatry patients who completed GAD7 or PHQ8 at their first visit and one subsequent visit. The first visit was between 2/1/23 and 5/26/23. ‘Not clinically significant' defined as a GAD7/PHQ8 score less than 10.

How it works